Lumexa Imaging Holdings, Inc. (LMRI)
Lumexa Imaging provides outpatient diagnostic imaging services, including MRI and CT scans, through centers in the United States. It last closed at $14.26 on Nov 20, up 1.42% on the day. The next earnings report for LMRI is expected around Mon, Mar 1, 2027. For the quarter ended Sep 2026, LMRI reported adjusted EPS of $0.26. Over its last 4 reports the stock moved an average of 13.5% the session after earnings. Over the last 12 months LMRI insiders bought $477K of stock on the open market and sold $0, according to SEC Form 4 filings.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →- Every upgrade, downgrade and initiation as it happens
- Every price target change, raised or cut
- Consensus rating with the average, high and low targets
- Each firm's full rating history on LMRI
Technical AnalysisPrices may be delayed
The stock is 7% above its 20 day and 18% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 63), near overbought. The nearest support is the Pivot at $14.20, and the nearest resistance the Pivot R1 at $14.53.
| RSI (14) | 62.61 | Strong, overbought above 70 | Neutral |
| MACD | 0.87 | Below its signal line | Bearish |
| Stochastic | 55.1 | Middle of its range | Neutral |
| ADX (14) | 45.9 | Strong uptrend | |
| Williams %R | -42.2 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 46.6 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +6.2% | Change over 10 sessions | Bullish |
| ATR (14) | $0.79 | Typical daily range, 5.5% of price |
| RSI (14) | 60.52 | Strong, overbought above 70 | Neutral |
| MACD | 0.34 | Above its signal line | Bullish |
| Stochastic | 75.3 | Middle of its range | Neutral |
| ADX (14) | 25.3 | Trending up | |
| Williams %R | -34.8 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 214.0 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +24.1% | Change over 10 sessions | Bullish |
| ATR (14) | $1.67 | Typical daily range, 11.7% of price |
What happened before
See how LMRI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options FlowPrices may be delayed
90DNo whale options trades in LMRI in the last 90 days.
LMRI Institutional Ownership
Full report →- ●57 buying vs 54 selling
- ●Held by funds +0.2 pts
- ▲Funds holding +7
- ▼Superinvestors: 1 added, 2 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 110 | 103 | +6.8% |
| In funds' top 10 | 1 | 1 | 0.0% |
| Held by funds | 32.9% | 32.7% | +0.2 pts |
| New / increased | 27 / 30 | 31 / 31 | −8.1% |
| Reduced / sold out | 34 / 20 | 29 / 17 | +17.4% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
LMRI Insider Trading
All filings →| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19 | Brett BrodnaxDirector | Buy | 35,000 | $7.25 | $254K |
| May 14 | Henry Lee CooperDirector | Buy | 30,000 | $7.44 | $223K |
From SEC Form 4 filings by LMRI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper tradingStreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LMRI is in one of them and how their past LMRI trades turned out.
LMRI News Tone and PricePrices may be delayed
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered LMRI in an article yet. Here's the latest on the wider market.
About Lumexa Imaging Holdings
Lumexa Imaging is a provider of outpatient diagnostic imaging services based in Raleigh, North Carolina. It operates imaging centers in metropolitan areas across several states in the United States, offering scans such as MRI and CT. Its customers include patients, referring physicians, health systems and payors, and it also works with health systems through joint ventures.
- Headquarters
- Raleigh, NC


